Immunotherapeutic and Targeted Approaches in Multiple Myeloma by Nadeem O, Tai YT, Anderson KC

Get full text

Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor by Joseph NS, Tai YT, Anderson KC, Lonial S

Get full text

An update on imatinib mesylate therapy in chronic myeloid leukaemia patients in a teaching hospital in Malaysia by Bee, P.C., Gan, G.G., Tai, Y.T., Haris, A.R., Chin, E., Veera, S.N.

Tripartite suppression of fission yeast torc1 signaling by the gator1-sea3 complex, the tsc complex, and gcn2 kinase by Fukuda, T., Sofyantoro, F., Tai, Y.T., Chia, K.H., Matsuda, T., Murase, T., Morozumi, Y., Tatebe, H., Kanki, T., Shiozaki, K.

Genomic landscape and chronological reconstruction of driver events in multiple myeloma by Maura, F, Bolli, N, Angelopoulos, N, Dawson, KJ, Leongamornlert, D, Martincorena, I, Mitchell, TJ, Fullam, A, Gonzalez, S, Szalat, R, Abascal, F, Rodriguez-Martin, B, Samur, MK, Glodzik, D, Roncador, M, Fulciniti, M, Tai, YT, Minvielle, S, Magrangeas, F, Moreau, P, Corradini, P, Anderson, KC, Tubio, JMC, Wedge, DC, Gerstung, M, Avet-Loiseau, H, Munshi, N, Campbell, PJ